Orford Keith 4
4 · Calithera Biosciences, Inc. · Filed Nov 9, 2021
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Award
Common Stock
2021-11-05+30,000→ 196,094 total - Sale
Common Stock
2021-11-09$0.84/sh−51,810$43,520→ 144,284 total
Footnotes (2)
- [F1]The shares of Common Stock were acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.832 to $0.850424, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.